Verteporfin Inhibits Severe Fever with Thrombocytopenia Syndrome Virus Infection via Inducing the Degradation of the Viral Gn Protein
<b>Background:</b> Severe fever with thrombocytopenia syndrome virus (SFTSV) is a novel tick-borne bunyavirus, causing the hemorrhagic infectious disease of SFTS, with a case fatality rate up to 30% due to the absence of effective therapeutic interventions. Therefore, it is urgent to dev...
Saved in:
| Main Authors: | Bingan Wu, Chenyang Yu, Yuxiang Lin, Ping Zhao, Zhongtian Qi, Xijing Qian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/4/434 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Verteporfin is an effective inhibitor of HCMV replication
by: Woo Young Lim, et al.
Published: (2024-12-01) -
Latest advances and prospects in the pathogenesis, animal models, and vaccine research of severe fever with thrombocytopenia syndrome virus
by: Chenghao Chen, et al.
Published: (2025-06-01) -
Verteporfin: A Novel Antiproliferative Agent for Urinary Tract Fibrosis?
by: Jas Singh
Published: (2022-01-01) -
Transmission of Severe Fever with Thrombocytopenia Syndrome Virus to Human from Nonindigenous Tick Host, Japan
by: Qiang Xu, et al.
Published: (2024-11-01) -
Analysis of Changes in Viral Load and Inflammatory Cytokines, as Well as the Occurrence of Secondary Infections, in SFTS Patients Treated with Specific Treatments: A Prospective Multicenter Cohort Study
by: Jun-Won Seo, et al.
Published: (2024-12-01)